EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort

Yajas Shah iD, Scott Kulm, Jones T Nauseef, Zhengming Chen, Olivier Elemento, Kevin H Kensler iD, Ravi N Sharaf

PLOS Computational Biology · 10.04.2024 · 20 (4) · e1011990

DOI: 10.1371/journal.pcbi.1011990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 10.04.2024. Verfasst von Yajas Shah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Englander Institute for Precision Medicine, Weill Cornell Medicine, New York City, New York, United States of America. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Benchmarking, Genetic Predisposition to Disease, Algorithms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer is a heritable disease with ancestry-biased incidence and mortality. Polygenic risk scores (PRSs) offer promising advancements in predicting disease risk, including prostate cancer. While their accuracy continues to improve, research aimed at enhancing their effectiveness within African and Asian populations remains key for equitable use. Recent algorithmic developments for PRS derivation have resulted in improved pan-ancestral risk prediction for several diseases. In this study, we benchmark the predictive power of six widely used PRS derivation algorithms, including four of which adjust for ancestry, against prostate cancer cases and controls from the UK Biobank and All of Us cohorts. We find modest improvement in discriminatory ability when compared with a simple method that prioritizes variants, clumping, and published polygenic risk scores. Our findings underscore the importance of improving upon risk prediction algorithms and the sampling of diverse cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBenchmarkingGenetic Predisposition to DiseaseAlgorithmsMultifactorial InheritanceHumansMaleCohort StudiesRisk FactorsPolymorphism, Single NucleotideGenome-Wide Association StudyComputational BiologyRisk AssessmentCase-Control StudiesGenetic Risk Score

Autor:innen und Institutionen

  • Englander Institute for Precision Medicine, Weill Cornell Medicine, New York City, New York, United States of America.
  • Department of Physiology and Biophysics, Weill Cornell Medicine, New York City, New York, United States of America.
  • Department of Medicine-Hematology and Medical Oncology, Weill Cornell Medicine, New York City, New York, United States of America.
  • Department of Population Health Sciences, Weill Cornell Medicine, New York City, New York, United States of America.
  • Department of Medicine-Gastroenterology and Hepatology, Weill Cornell Medicine, New York City, New York, United States of America.

ORCID-Profile: Yajas Shah, Kevin H Kensler

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Shah, Y., Kulm, S., Nauseef, J. T., Chen, Z., Elemento, O., Kensler, K. H., & Sharaf, R. N. (2024). Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort. PLOS Computational Biology, 20(4), e1011990. https://doi.org/10.1371/journal.pcbi.1011990

Vancouver

Shah Y, Kulm S, Nauseef JT, Chen Z, Elemento O, Kensler KH, et al. Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort. PLOS Computational Biology. 2024;20(4):e1011990. doi:10.1371/journal.pcbi.1011990

BibTeX
@article{Shah2024,
  author = {Shah, Yajas and Kulm, Scott and Nauseef, Jones T and Chen, Zhengming and Elemento, Olivier and Kensler, Kevin H and Sharaf, Ravi N},
  title = {Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort},
  journal = {PLOS Computational Biology},
  year = {2024},
  volume = {20},
  number = {4},
  pages = {e1011990},
  doi = {10.1371/journal.pcbi.1011990}
}
Kostenlos starten →